All filters
Slidesets
Integration of Hepatitis C Treatment Services with Harm Reduction Service Centers for People who Inject Drugs in Kenya: Experience from Test and Link to Care for Injecting Drug Users Study- M. Nyakowa
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Towards the Elimination of HCV in British Columbia: A strategy to Address the “messy middle”- B. Conway
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario- D. Smookler
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study- A. Palayew
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Mongolia’s Model for Care- Naranjargal Dashdorj, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Hepatitis C Elimination in the Netherlands (CELINE): a Nationwide Study Retrieving Lost to Follow-Up Chronic Hepatitis C Patients- M. Van Dijk
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Oral Prescription Opioid Use should be Considered a Risk Factor for HCV Infection: Another Step Toward HCV Elimination- B. Hack
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Videos
Study Design with New Combinations - Marion Peters, MD
Presented at:
International Workshop on HBV Cure 2019
Videos
Hypothesized Synergies in New Combination Treatment Beyond NUCs - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2019
Videos
NAP's Latest Update in HBV and HDV - Andrew Vaillant, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
sIRNA-Based Therapy for Chronic Hepatitis B Treatment - Michael Biermer, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
Capsid Inhibitor/cccDNA Inhibitor--Roche - Lu Gao, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
Gilead TLR8 Agonist (GS-9688) - Simon Fletcher, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
Using FNAB to Investigate Intrahepatic Immunology - Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
Restoration of B Cell Antibody Production in Chronic HBV Patients - Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
High Resolution of Exhausted T Cells Ex Vivo in Chronic HBV Infection - Robert Thimme, MD
Presented at:
International Workshop on HBV Cure 2019
Videos
Are ALT Flares Associated with Improved Virological Clearance? - Harry L.A. Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
Are HBcrAg, HBV RNA and anti-HBc Viable Biomarkers? - Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Videos
Review of the FDA/EMA HBV Endpoints Meeting - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Videos
Virological Biomarkers in Patients Stopping NUCs - Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Videos
Stopping Nucleos(t)ide Analogues - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2019